Literature DB >> 10571288

Improvement of the intestinal absorption of a peptidomimetic, boronic acid thrombin inhibitor possibly utilizing the oligopeptide transporter.

H Saitoh1, B J Aungst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571288     DOI: 10.1023/a:1011989504054

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  11 in total

1.  New inhibitors of thrombin and other trypsin-like proteases: hydrogen bonding of an aromatic cyano group with a backbone amide of the P1 binding site replaces binding of a basic side chain.

Authors:  S L Lee; R S Alexander; A Smallwood; R Trievel; L Mersinger; P C Weber; C Kettner
Journal:  Biochemistry       Date:  1997-10-28       Impact factor: 3.162

2.  Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in rats.

Authors:  M A Hussain; R Knabb; B J Aungst; C Kettner
Journal:  Peptides       Date:  1991 Sep-Oct       Impact factor: 3.750

3.  Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist.

Authors:  B J Aungst; H Saitoh
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

4.  Restricted intestinal absorption of some beta-lactam antibiotics by an energy-dependent efflux system in rat intestine.

Authors:  H Saitoh; H Fujisaki; B J Aungst; K Miyazaki
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

5.  The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption.

Authors:  H Saitoh; C Gerard; B J Aungst
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

6.  The selective inhibition of thrombin by peptides of boroarginine.

Authors:  C Kettner; L Mersinger; R Knabb
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

Review 7.  Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.

Authors:  C Tapparelli; R Metternich; C Ehrhardt; N S Cook
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

Review 8.  Challenges in the development of orally bioavailable thrombin active site inhibitors.

Authors:  S D Kimball
Journal:  Blood Coagul Fibrinolysis       Date:  1995-09       Impact factor: 1.276

9.  Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group.

Authors:  P F Bai; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

10.  Molecular modeling study of structural requirements for the oligopeptide transporter.

Authors:  J Li; I J Hidalgo
Journal:  J Drug Target       Date:  1996       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.